BPDCN international registry for patients to be followed over time
Part of Blood & lymphatic, Cancer, Skin clinical trials.
This trial is a patient registry for people with blastic plasmacytoid dendritic cell neoplasm (BPDCN). It helps researchers learn more about the disease by collecting information from patients as they get care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of BPDCN.
- You (or your legal guardian) must be able to sign a consent form to join.
- You will need to follow the registry’s instructions for sharing medical information.
- There are no listed medical reasons to exclude you in the criteria provided.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at the health records of people who were treated for BPDCN (a rare blood cancer) with chemotherapy as their first treatment. The goal is to learn more about how the disease progresses and how well treatments work in the real world. If you meet the criteria, your past medical data may be included.
This study follows people with a rare blood cancer called BPDCN who are starting or recently started a medicine called Elzonris (tagraxofusp). It collects health information to see how the treatment works over time.
This trial tests a combination of two targeted drugs (tagraxofusp and venetoclax) for people with a rare blood cancer called BPDCN who have not been treated before. The goal is to see if this combination is safe and effective as a first treatment.
This trial is building a registry (a collection of samples and health information) for people with bile duct or pancreas diseases. By joining, you help researchers study these conditions to improve future treatments.
This study keeps a patient registry to collect information about people with specific myeloid blood neoplasms (a type of blood cancer). It helps researchers understand these conditions over time and may improve how patients are cared for in the future.
This study builds a database of people diagnosed with pancreatic tumors. It may help researchers better understand these cancers by collecting medical information over time.
Hear when a new Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.